Functional Imaging in HNC Undergoing Chemoradiation
Investigation of the Role of Functional Imaging in Characterising Radiotherapy Target Volumes and Assessing Disease Response in Patients Undergoing Chemoradiation for Head and Neck Cancer (HNC)
1 other identifier
observational
10
1 country
1
Brief Summary
The purpose of the study is to generate a library of functional imaging and anatomical imaging for patients with head and neck cancers for evaluation of new radiotherapy strategies and planning techniques including IMRT. Secondary aims would be to observe the changes in the cancers as the treatment progresses as well as to define the biologically most active part of the tumor (biological target volume) which could be given more intensive treatment. Tumor volumes seen on different imaging modalities will be compared with a hope of finding an optimal imaging methodology for accurate visualization of the head and neck cancers
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2009
CompletedFirst Submitted
Initial submission to the registry
February 5, 2009
CompletedFirst Posted
Study publicly available on registry
February 6, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2010
CompletedFebruary 6, 2009
February 1, 2009
1.7 years
February 5, 2009
February 5, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the number of patients completing the study protocol and adding to the library of images to be used for evaluation of new radiotherapy strategies and planning techniques including IMRT
Secondary Outcomes (3)
the ability to define a biological target volume in all the patients
to compare the volumes defined by the conventional imaging to the functional imaging
to measure changes in the volume of the disease with diff
Eligibility Criteria
Adult patients who have a head and neck cancer and are planned to receive chemotherapy and radiotherapy will be invited to participate in the study. Patients who are not in very good health, have diabetes or kidney failure will not be considered for the study. Also patients who can not undergo MRI scan or are allergic to contrast injection given prior to the scan or have had any other form of cancer (except skin cancer) will also be excluded from the study.
You may qualify if:
- patients with histologically proven head and neck cancer, planed for chemotherapy and radiotherapy
- age more than 18 years
- patient willing to participate and has signed a consent form
- patients in good physical status (WHO performance status 0-2)
You may not qualify if:
- patients in poor health (WHO performance status \>2)
- patients with any other cancer apart from skin cancer
- patients with contraindications to MRI scan and IV contrast
- diabetic patients
- patients with renal failure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Royal Marsden NHS Foundation Trust
Sutton, Surrey, SM6 9QD, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 5, 2009
First Posted
February 6, 2009
Study Start
February 1, 2009
Primary Completion
November 1, 2010
Study Completion
November 1, 2010
Last Updated
February 6, 2009
Record last verified: 2009-02